These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9128855)

  • 1. A rapid and reversible change in dopamine transporters induced by methamphetamine.
    Fleckenstein AE; Metzger RR; Gibb JW; Hanson GR
    Eur J Pharmacol; 1997 Apr; 323(2-3):R9-10. PubMed ID: 9128855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
    Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
    J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and reversible effects of methamphetamine on dopamine transporters.
    Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
    Kokoshka JM; Vaughan RA; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 1998 Nov; 361(2-3):269-75. PubMed ID: 9865517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.
    Sandoval V; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2000 Dec; 409(3):265-71. PubMed ID: 11108820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain.
    Kokoshka JM; Metzger RR; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Brain Res; 1998 Jul; 799(1):78-83. PubMed ID: 9666084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?
    Hanson GR; Gibb JW; Metzger RR; Kokoshka JM; Fleckenstein AE
    Ann N Y Acad Sci; 1998 May; 844():103-7. PubMed ID: 9668668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new in vitro approach for investigating the MPTP effect on DA uptake.
    Barc S; Page G; Fauconneau B; Barrier L; Huguet F
    Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes.
    Bougria M; Vitorica J; Cano J; Machado A
    Eur J Pharmacol; 1995 Nov; 291(3):407-15. PubMed ID: 8719427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes.
    Cowell RM; Kantor L; Hewlett GH; Frey KA; Gnegy ME
    Eur J Pharmacol; 2000 Feb; 389(1):59-65. PubMed ID: 10686296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
    Frey K; Kilbourn M; Robinson T
    Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function.
    Fleckenstein AE; Haughey HM; Metzger RR; Kokoshka JM; Riddle EL; Hanson JE; Gibb JW; Hanson GR
    Eur J Pharmacol; 1999 Oct; 382(1):45-9. PubMed ID: 10556503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function.
    Metzger RR; Hanson GR; Gibb JW; Fleckenstein AE
    Eur J Pharmacol; 1998 May; 349(2-3):205-10. PubMed ID: 9671099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens.
    Richards TL; Zahniser NR
    J Neurochem; 2009 Mar; 108(6):1575-84. PubMed ID: 19183252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal by [D-Ala2,D-Leu5]enkephalin of the dopamine transporter loss caused by methamphetamine.
    Tsao LI; Cadet JL; Su TP
    Eur J Pharmacol; 1999 May; 372(3):R5-7. PubMed ID: 10395030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regional effects of methamphetamine on dopamine transport.
    Chu PW; Seferian KS; Birdsall E; Truong JG; Riordan JA; Metcalf CS; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2008 Aug; 590(1-3):105-10. PubMed ID: 18599036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine.
    Kokoshka JM; Fleckenstein AE; Wilkins DG; Hanson GR
    J Neurochem; 2000 Nov; 75(5):2095-102. PubMed ID: 11032899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.
    Wilson JM; Kalasinsky KS; Levey AI; Bergeron C; Reiber G; Anthony RM; Schmunk GA; Shannak K; Haycock JW; Kish SJ
    Nat Med; 1996 Jun; 2(6):699-703. PubMed ID: 8640565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters.
    Fleckenstein AE; Beyeler ML; Jackson JC; Wilkins DG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1997 Apr; 324(2-3):179-86. PubMed ID: 9145769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.